Heterocyclic compounds and uses thereof
US-8969363-B2 · Mar 3, 2015 · US
Toll like receptor modulator compounds
US9670205B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9670205-B2 |
| Application number | US-201615059070-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 2, 2016 |
| Priority date | Mar 4, 2015 |
| Publication date | Jun 6, 2017 |
| Grant date | Jun 6, 2017 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present disclosure relates generally to toll like receptor modulator compounds, such as diamino pyrido[3,2 D]pyrimidine compounds and pharmaceutical compositions which, among other things, modulate toll-like receptors (e.g. TLR-8), and methods of making and using them.
First claim
Opening claim text (preview).
We claim: 1. A compound which is or a pharmaceutically acceptable salt thereof. 2. A compound which is 3. A pharmaceutical composition comprising the compound of claim 1 or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable excipient. 4. A pharmaceutical composition comprising the compound of claim 2 , and a pharmaceutically acceptable excipient. 5. A compound which is or a pharmaceutically acceptable salt thereof. 6. A compound which is 7. A pharmaceutical composition comprising the compound of claim 5 or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable excipient. 8. A pharmaceutical composition comprising the compound of claim 6 , and a pharmaceutically acceptable excipient. 9. A compound which is or a pharmaceutically acceptable salt thereof. 10. A compound which is 11. A pharmaceutical composition comprising the compound of claim 9 or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable excipient. 12. A pharmaceutical composition comprising the compound of claim 10 , and a pharmaceutically acceptable excipient. 13. A compound which is or a pharmaceutically acceptable salt thereof. 14. A compound which is 15. A pharmaceutical composition comprising the compound of claim 13 or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable excipient. 16. A pharmaceutical composition comprising the compound of claim 14 , and a pharmaceutically acceptable excipient.
Assignees
Inventors
Classifications
directly linked by a ring-member-to-ring-member bond · CPC title
Nitrogen atoms · CPC title
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
Drugs for immunological or allergic disorders · CPC title
specific for metastasis · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9670205B2 cover?
- The present disclosure relates generally to toll like receptor modulator compounds, such as diamino pyrido[3,2 D]pyrimidine compounds and pharmaceutical compositions which, among other things, modulate toll-like receptors (e.g. TLR-8), and methods of making and using them.
- Who is the assignee on this patent?
- Gilead Sciences Inc
- What technology area does this patent fall under?
- Primary CPC classification A61P31/18. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jun 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).